Position in ARGX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,408,354
+$287,421 QoQ
Shares Held
1,518
-1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#225
of 506 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NVWM, LLC holds $2,347,266 across 18 Biotechnology names. ARGX ranks #1 (60.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
1,518 | $1,408,354 | |
| 2 | CYTK |
Cytokinetics Inc
|
9,123 | $777,187 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125 | $77,941 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,000 | $26,220 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
416 | $19,568 | |
| 6 | MANE |
Veradermics, Inc
|
111 | $13,646 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
165 | $6,436 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,408,354 | 1,518 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,120,933 | 1,535 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $794,697 | 945 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $708,794 | 961 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $536,336 | 973 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $579,435 | 979 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $603,315 | 981 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $533,406 | 984 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||